Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-15

Clinical Trial Update: Long-Term Olanzapine Treatment in Children With Autism [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 clinical trial evaluating long-term olanzapine treatment in children with autism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • olanzapine (olanzapine)

Snippet

Sponsor: Drexel University | Conditions: Autism | Phase 2, Phase 3 | Status: COMPLETED